Company Filing History:
1 out of 1,309 
1 out of 3,539 
Years Active: 2009
Title: Innovations of Rebecca Suzanne McHugh
Introduction
Rebecca Suzanne McHugh is a notable inventor based in Wellington, New Zealand. She has made significant contributions to the field of immunology through her innovative research and development of therapeutic methods. Her work focuses on addressing immune cell-associated pathologies, which has important implications for treating various diseases.
Latest Patents
Rebecca holds a patent for a method of treating or ameliorating an immune cell-associated pathology using GITR ligand antibodies. The present invention provides novel isolated and purified polynucleotides and polypeptides related to a novel ligand for glucocorticoid-induced TNF receptor (GITR). This invention also includes antibodies to the GITR ligand (GITRL) and is directed towards novel methods for diagnosing, prognosing, monitoring the progress of, and treating disorders arising from dysregulation of the immune system. These disorders include autoimmune disorders, inflammatory diseases, transplant rejection, cancers, and infectious diseases. The invention aims to utilize GITRL and/or modulators of GITRL for intervention and prevention of these disorders.
Career Highlights
Throughout her career, Rebecca has worked with prominent organizations such as Wyeth and the National Institutes of Health, a component of the US Department of Health & Human Services. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Rebecca has collaborated with notable colleagues, including Mary Collins and Ethan Shevach. These partnerships have enhanced her research and expanded the impact of her innovations in immunology.
Conclusion
Rebecca Suzanne McHugh is a pioneering inventor whose work in immunology has the potential to transform the treatment of various immune-related disorders. Her innovative approaches and collaborations continue to advance the field and improve patient outcomes.